1 Min Read
May 3 (Reuters) - PharmAthene Inc
* PharmAthene reports first quarter 2017 financial and operational results
* Q1 loss per share $0.03
* Q1 revenue $800,000 versus $1.0 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.